AZTREONAM FOR INHALATION SOLUTION (AZLI) TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS (CF) AND CHRONIC PSEUDOMONAS AERUGINOSA (PA) INFECTION

被引：0
|
作者：
Accurso, F. J. [1 ]
Fayon, M. [2 ]
Sermet, I. [3 ]
Lewis, S. [4 ]
Bresnik, M. [5 ]
Oermann, C. M. [6 ]
机构：
[1] UCD Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA
[2] CHU Bordeaux, CIC 0005, Bordeaux, France
[3] Hop Necker Enfants Malad, CHU Paris, Paris, France
[4] Gilead Sci Inc, Seattle, WA USA
[5] Gilead Sci Inc, Foster City, CA 94404 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
来源：
PEDIATRIC PULMONOLOGY | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [21] A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection
    Retsch-Bogart, George Z.
    Burns, Jane L.
    Otto, Kelly L.
    Liou, Theodore G.
    McCoy, Karen
    Oermann, Christopher
    Gibson, Ronald L.
    PEDIATRIC PULMONOLOGY, 2008, 43 (01) : 47 - 58
  • [22] Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Bilton, Diana
    Pressler, Tacjana
    Fajac, Isabelle
    Clancy, John Paul
    Sands, Dorota
    Minic, Predrag
    Cipolli, Marco
    Galeva, Ivanka
    Sole, Amparo
    Quittner, Alexandra L.
    Liu, Keith
    McGinnis, John R., II
    Eagle, Gina
    Gupta, Renu
    Konstan, Michael W.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (02) : 284 - 291
  • [23] Maintenance treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Hoiby, N
    Koch, C
    THORAX, 2000, 55 (05) : 349 - 350
  • [24] Treatment of chronic Pseudomonas aeruginosa infection of the lungs in cystic fibrosis
    Hubert, D
    Desmazes-Dufeu, N
    Dusser, D
    REVUE DES MALADIES RESPIRATOIRES, 2003, 20 (02) : S129 - S135
  • [25] Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
    McCoy, Karen S.
    Quittner, Alexandra L.
    Oermann, Christopher M.
    Gibson, Ronald L.
    Retsch-Bogart, George Z.
    Montgomery, A. Bruce
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (09) : 921 - 928
  • [26] PHARMACOKINETIC (PK) PROFILE OF LIPOSOMAL AMIKACIN FOR INHALATION (LAI) IN PATIENTS WITH CYSTIC FIBROSIS (CF) AND CHRONIC PSEUDOMONAS AERUGINOSA INFECTION
    Clancy, J. P.
    Konstan, M.
    Fajac, I
    Pressler, T.
    Sands, D.
    Minic, P.
    Cipolli, M.
    Bilton, D.
    Eagle, G.
    McGinnis, J.
    Monroe, R.
    Rubino, C.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 358 - 359
  • [27] Aztreonam Lysine for Inhalation Solution In Cystic Fibrosis
    Plosker, Greg L.
    DRUGS, 2010, 70 (14) : 1843 - 1855
  • [28] Aztreonam for Inhalation Solution (Cayston) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1344): : 63 - 64
  • [29] Aztreonam Lysine Inhalation Solution in Cystic Fibrosis
    Elson, Elizabeth Claire
    Mermis, Joel
    Polineni, Deepika
    Oermann, Christopher M.
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2019, 13
  • [30] Early eradication of pseudomonas aeruginosa (PA) in cystic fibrosis patients (CF): Which is the best treatment?
    Teper, Alejandro
    Villagra, Guillermo
    Fili, Silvana
    Lubovich, Silvina
    Zaragoza, Silvina
    Rodriguez, Viviana
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345